[1]
Muhamad, S.A. 2025. HARNESSING 68GA-NOTA-RITUXIMAB IN RADIOIMMUNOTHERAPY (RIT) : REVOLUTIONIZING CANCER TREATMENT. JOURNAL of NUCLEAR and Related TECHNOLOGIES. 22, 1 (Jul. 2025), 38-45.